(234 days)
No
The device description and performance studies focus on the physical characteristics, materials, and mechanical performance of dental implants and abutments, with no mention of software, algorithms, or AI/ML capabilities.
Yes
The device is a dental implant intended to provide support for fixed or removable dental prostheses, restoring chewing function, which is a therapeutic purpose.
No
This device is a dental implant intended for implantation and provides support for dental prostheses; it does not perform diagnostic functions.
No
The device description clearly outlines physical components made of titanium and gold alloys, such as implants, abutments, and screws, which are hardware.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a device for surgical implantation in the body to support dental prostheses. This is a therapeutic and structural function, not a diagnostic one performed on samples outside the body.
- Device Description: The device is a physical implant and associated components (abutments, screws) designed to be placed within the patient's jawbone.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening.
Therefore, the Southern Implants MAX implant is a medical device, specifically a dental implant, and not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
Southern Implants MAX implant is intended for implantation in the maxillary or mandibular molar region where bone exists and the surgeon has determined that the placement of a narrower diameter implant would increase the probability of failure due to poor primary stability, or increased surgical procedures leading to complications. This MAX implant provides support for fixed or removable dental prostheses in a single tooth, partially edentulous prostheses or full arch prostheses. It further adds the option for immediate loading on single and splinted multiple unit restorations when good primary stability is achieved and with appropriate occlusal loading, to restore chewing function.
Product codes
DZE, NHA
Device Description
This submission includes threaded root-form dental implants with an external hex and internal tri-lobe interface and mating abutments. The implants are provided in diameters of 6, 7, 8 and 9mm and lengths of 6, 7, 9 and 11mm. Specifically:
- MAX Implants with External Hex Connection .
- o Ø6 mm at lengths of 6, 7, 9, 11 mm
- o Ø7 mm at lengths of 7, 9, 11 mm
- Ø8 mm at lengths of 7, 9, 11 mm O
- Ø9 mm at lengths of 7, 9, 11 mm O
- TRIMAX Implants with Tri-lobe Connection
- Ø7 mm at lengths of 7, 9, 11 mm o
- Ø8 mm at lengths of 7, 9, 11 mm O
- Ø9 mm at lengths of 7, 9, 11 mm O
- PROMAX Implants with Internal Hex Connection ●
- Ø6 mm at lengths of 7, 9, 11 mm O
- Ø7 mm at lengths of 7, 9, 11 mm O
- Ø8 mm at lengths of 7, 9, 11 mm O
- Ø9 mm at lengths of 7, 9, 11 mm O
This submission also includes: Coverscrews in two diameters and implant connection interfaces: Healing Abutments in two implant connection interfaces (tri-lobe and internal hex) with lengths between 3 and 6mm and diameters between 6 and 7.8mm; Titanium Cylinder abutments for temporary restorations in two implant connection interfaces (tri-lobe and internal hex) in engaging and non-engaging configurations; Cosmetic Abutments for permanent restorations in two engaging implant connection interfaces (tri-lobe and internal hex); Gold Cylinder Abutments for permanent restorations in three implant connection interfaces (external hex, tri-lobe and internal hex) in engaging and non-engaging configurations; Passive Abutments for permanent restorations in two implant connection interfaces (trilobe and internal hex) in engaging and non-engaging configurations; Compact Conical abutments in an internal hex connection for multi-unit restorations; and abutment screws. The Gold Cylinder Abutments and Passive Abutments are UCLA castable abutments which interface with a plastic, burn-out sleeve used to fabricate a prosthesis that is bonded directly to the top of the abutment.
All MAX implants are manufactured from unalloyed titanium conforming to ASTM F67. The implant surface is grit blasted with varying lengths of unroughened coronal portions. The Cover Screw, Healing Abutment, Titanium Cylinder Abutment, Cosmetic Abutment and Passive Abutment are manufactured from unalloyed titanium conforming to ASTM F67. The Gold Cylinder Abutment is manufactured from a gold alloy. The Compact Conical Abutments manufactured from titanium alloy conforming to ASTM F136. The abutment screws are manufactured from titanium alloy conforming to ASTM F136, or goldplatinum alloy. All subject device components are manufactured in the same facilities using the same materials and manufacturing processes as used for the Southern Implants devices previously cleared in K071161, K163634, K070905 and K180465.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
maxillary or mandibular molar region
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical data submitted, referenced, or relied upon to demonstrate substantial equivalence include: biocompatibility (referenced from K071161 and K180465); engineering analysis; dimensional analysis; sterilization validation according to ISO 11137-1, ISO 11137-2, ISO 17665-1, ISO TS 17665-2; bacterial endotoxin according to USP 39-NF34; sterile barrier shelf life (referenced from K071161). Pull out tests and surface area analysis comparing the worst-case subject device to the predicate device were performed. No clinical data were included in this submission.
Key Results:
- Substantial equivalence of the subject device components in terms of biocompatibility is supported by the fact that materials are identical in formulation, processing, component interactions, and storage conditions to the primary predicate device K071161 and reference devices K163634 and K180465.
- Engineering analysis and dimensional analysis was performed and demonstrated fatigue performance of the subject device to be substantially equivalent to that of the predicate device K071161and reference devices K163634 and K180465.
- Pullout tests and surface area analysis demonstrated that the subject device is substantially equivalent to the reference device K163634.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. Underneath the square are the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
December 9, 2019
Southern Implants (Pty) Ltd Lauranda Breytenbach Head of Regulatory Affairs and Quality 1 Albert Road Irene, Gauteng 0062 SOUTH AFRICA
Re: K191054
Trade/Device Name: Southern Implants MAX Implant System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE, NHA Dated: September 6, 2019 Received: September 10, 2019
Dear Lauranda Breytenbach:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
for Srinivas Nandkumar, Ph.D. Director DHT1B: Division of Dental Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K191054
Device Name Southern Implants MAX Implant System
Indications for Use (Describe)
Southern Implants MAX implant is intended for implantation in the maxillary or mandibular molar region where bone exists and the surgeon has determined that the placement of a narrower diameter implant would increase the probability of failure due to poor primary stability, or increased surgical procedures leading to complications. This MAX implant provides support for fixed or removable dental prostheses in a single tooth, partially edentulous prostheses or full arch prostheses. It further adds the option for immediate loading on single unit restorations when good primary stability is achieved and with appropriate occlusal loading, to restore chewing function.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW *
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary Southern Implants MAX Implant System Southern Implants (Pty) Ltd December 9, 2019
K191054
ADMINISTRATIVE INFORMATION Manufacturer Name
Southern Implants (Pty) Ltd 1 Albert Road Irene, Gauteng, 0062 South Africa +27 12 667 1046 Telephone Fax +27 12 667 1029
Official Contact
Lauranda G. Breytenbach Head of Regulatory Affairs and Quality Email: lauranda.b@southernimplants.com
DEVICE NAME AND CLASSIFICATION Trade/Proprietary name Common name
Classification name Classification regulation Product Code
Classification Panel Reviewing Branch
Southern Implants MAX Implant System Dental Implant
Endosseous dental implant 21 CFR 872.3640, Class II DZE, NHA
Dental Products Panel Dental Devices Branch
PREDICATE DEVICE INFORMATION The primary predicate device is K071161 The reference devices are K163634, K070905 and K180465
4
INDICATIONS FOR USE STATEMENT
Southern Implants MAX implant is intended for implantation in the maxillary or mandibular molar region where bone exists and the surgeon has determined that the placement of a narrower diameter implant would increase the probability of failure due to poor primary stability, or increased surgical procedures leading to complications. This MAX implant provides support for fixed or removable dental prostheses in a single tooth, partially edentulous prostheses or full arch prostheses. It further adds the option for immediate loading on single and splinted multiple unit restorations when good primary stability is achieved and with appropriate occlusal loading, to restore chewing function.
SUBJECT DEVICE DESCRIPTION
This submission includes threaded root-form dental implants with an external hex and internal tri-lobe interface and mating abutments. The implants are provided in diameters of 6, 7, 8 and 9mm and lengths of 6, 7, 9 and 11mm. Specifically:
- MAX Implants with External Hex Connection .
- o Ø6 mm at lengths of 6, 7, 9, 11 mm
- o Ø7 mm at lengths of 7, 9, 11 mm
- Ø8 mm at lengths of 7, 9, 11 mm O
- Ø9 mm at lengths of 7, 9, 11 mm O
- TRIMAX Implants with Tri-lobe Connection
- Ø7 mm at lengths of 7, 9, 11 mm o
- Ø8 mm at lengths of 7, 9, 11 mm O
- Ø9 mm at lengths of 7, 9, 11 mm O
- PROMAX Implants with Internal Hex Connection ●
- Ø6 mm at lengths of 7, 9, 11 mm O
- Ø7 mm at lengths of 7, 9, 11 mm O
- Ø8 mm at lengths of 7, 9, 11 mm O
- Ø9 mm at lengths of 7, 9, 11 mm O
This submission also includes: Coverscrews in two diameters and implant connection interfaces: Healing Abutments in two implant connection interfaces (tri-lobe and internal hex) with lengths between 3 and 6mm and diameters between 6 and 7.8mm; Titanium Cylinder abutments for temporary restorations in two implant connection interfaces (tri-lobe and internal hex) in engaging and non-engaging configurations; Cosmetic Abutments for permanent restorations in two engaging implant connection interfaces (tri-lobe and internal hex); Gold Cylinder Abutments for permanent restorations in three implant connection interfaces (external hex, tri-lobe and internal hex) in engaging and non-engaging configurations; Passive Abutments for permanent restorations in two implant connection interfaces (trilobe and internal hex) in engaging and non-engaging configurations; Compact Conical abutments in an internal hex connection for multi-unit restorations; and abutment screws. The Gold Cylinder Abutments and Passive Abutments are UCLA castable abutments which interface with a plastic, burn-out sleeve used to fabricate a prosthesis that is bonded directly to the top of the abutment.
All MAX implants are manufactured from unalloyed titanium conforming to ASTM F67. The implant surface is grit blasted with varying lengths of unroughened coronal portions. The Cover Screw, Healing Abutment, Titanium Cylinder Abutment, Cosmetic Abutment and Passive Abutment are manufactured from unalloyed titanium conforming to ASTM F67. The Gold Cylinder Abutment is manufactured from a gold alloy. The Compact Conical Abutments manufactured from titanium alloy conforming to ASTM
5
F136. The abutment screws are manufactured from titanium alloy conforming to ASTM F136, or goldplatinum alloy. All subject device components are manufactured in the same facilities using the same materials and manufacturing processes as used for the Southern Implants devices previously cleared in K071161, K163634, K070905 and K180465.
PERFORMANCE DATA
Non-clinical data submitted, referenced, or relied upon to demonstrate substantial equivalence include: biocompatibility (referenced from K071161 and K180465); engineering analysis; dimensional analysis; sterilization validation according to ISO 11137-1, ISO 11137-2, ISO 17665-1, ISO TS 17665-2; bacterial endotoxin according to USP 39-NF34; sterile barrier shelf life (referenced from K071161). Pull out tests and surface area analysis comparing the worst-case subject device to the predicate device were performed. No clinical data were included in this submission.
EQUIVALENCE TO MARKETED DEVICE
Southern Implants (Pty) Ltd submits the information in this Premarket Notification to demonstrate that, for the purposes of FDA's regulation of medical devices, the subject device is substantially equivalent in indications and design principles to the following legally marketed devices: K071161, Endosseous Dental Implant, Southern Implants (Pty) Ltd
K163634, External Hex Implants, Southern Implants (Pty) Ltd
K070905, Endosseous Dental Implant, Southern Implants (Pty) Ltd
K180465, Provata Implant System, Southern Implants (Pty) Ltd
The primary predicate device is K071161.
The reference devices are K163634, K070905 and K180465
A comparison of the technological characteristics of the subject device and the primary predicate device K071161 is provided in the following table.
| Comparison | Subject device | Primary Predicate device |
|---|---|---|
| Indications for use statement | Southern Implants MAX implant is | |
| intended for implantation in the | ||
| maxillary or mandibular molar | ||
| region where bone exists and the | ||
| surgeon has determined that the | ||
| placement of a narrower diameter | ||
| implant would increase the | ||
| probability of failure due to poor | ||
| primary stability, or increased | ||
| surgical procedures leading to | ||
| complications. This MAX implant | ||
| provides support for fixed or | ||
| removable dental prostheses in a | ||
| single tooth, partially edentulous | ||
| prostheses or full arch prostheses. | ||
| It further adds the option for | ||
| immediate loading on single and | ||
| splinted multiple unit restorations | K071161, Endosseous Dental | |
| Implant, Southern Implants (Pty) | ||
| Ltd | ||
| NSI MAX implant is intended for | ||
| implantation in the maxillary or | ||
| mandibular molar region where | ||
| bone exists and the surgeon has | ||
| determined that the placement of a | ||
| narrower diameter implant would | ||
| increase the probability of failure | ||
| due to poor primary stability, or | ||
| increased surgical procedures | ||
| leading to complications. This | ||
| MAX implant provides support for | ||
| fixed or removable dental | ||
| prostheses in a single tooth, | ||
| partially edentulous prostheses or | ||
| full arch prostheses. It further adds | ||
| the option for immediate loading on | ||
| single and splinted multiple unit | ||
| restorations when good primary | ||
| when good primary stability is | ||
| achieved and with appropriate | ||
| occlusal loading, to restore chewing | ||
| function. | stability is achieved and with | |
| appropriate occlusal loading, to | ||
| restore chewing function. | ||
| Implant Design | ||
| Implant Diameter | 6, 7, 8, 9mm | 8, 9mm |
| Implant Length | 6, 7, 9, 11mm | 7, 9, 11, 13mm |
| Implant Platform Diameter | Ø4.5, 5.5, 5.7, 6.5, 7.5mm | Ø6.5, 7.5mm |
| Implant Prosthetic Diameter | Ø3.575, 4, 5, 5.575, 6, 7mm | Ø6, 7mm |
| Implant Interface | External hex | |
| Tri-lobe | ||
| Internal Hex | External hex | |
| Material | Unalloyed titanium (ASTM F67) | Unalloyed titanium (ASTM F67) |
| Implant endosseous surface | Grit-blasted | Grit-blasted |
| Cover Screw | ||
| Platform diameter | Ø5.575, 6mm | Ø7mm |
| Maximum diameter | Ø5.6, 6mm | Ø7mm |
| Material | Unalloyed titanium (ASTM F67), | |
| anodized | Unalloyed titanium (ASTM F67) | |
| Healing Abutment | ||
| Collar height | 3, 5, 6mm | 4, 5.5, 7mm |
| Collar diameter | 6, 7, 7.8mm | 8mm |
| Material | Unalloyed titanium (ASTM F67), | |
| anodized | Unalloyed titanium (ASTM F67) | |
| Titanium Cylinder Abutment | ||
| Connection configurations | Engaging (single-unit) and Non- | |
| engaging (Multi-unit) | Engaging (single-unit) and Non- | |
| engaging (Multi-unit) | ||
| Prosthesis Attachment | Cement-retained | Cement-retained |
| Collar height | 1, 3mm | 1mm |
| Collar diameter | 6.33, 6.55mm | 7.33mm |
| Abutment Angle | 0° | 0° |
| Abutment Material | Unalloyed titanium (ASTM F67), | |
| anodized | Unalloyed titanium (ASTM F67) | |
| Abutment Screw Material | Titanium Alloy (ASTM F136) or | |
| Gold Alloy | Titanium Alloy (ASTM F136) or | |
| Gold Alloy | ||
| Cosmetic Abutment | ||
| Connection configurations | Engaging | N/A |
| Prosthesis Attachment | Cement-retained | N/A |
| Collar height | Varying from 1.6mm to 2.9mm | N/A |
| Collar diameter | Varying from 6.86 mm to 7.92mm | N/A |
| Abutment Angle | 0° | N/A |
| Abutment Material | Unalloyed titanium (ASTM F67), | |
| anodized | N/A | |
| Abutment Screw Material | Titanium Alloy (ASTM F136) or | |
| Gold Alloy | N/A | |
| Gold Cylinder Abutment | ||
| Connection configurations | Engaging (single-unit) and Non- | |
| engaging (Multi-unit) | N/A | |
| Prosthesis Attachment | Screw-retained | N/A |
| Collar height | 0.5, 0.56, 0.64mm | N/A |
| Collar diameter | 4.3, 6.15, 6.45, 7.15mm | N/A |
| Abutment Angle | 0° | N/A |
| Abutment Material | Gold Alloy | N/A |
| Abutment Screw Material | N/A | |
| Titanium Alloy (ASTM F136) or | ||
| Gold Alloy | ||
| Passive Abutment | ||
| Connection configurations | Engaging (single-unit) and Non- | |
| engaging (Multi-unit) | Engaging (single-unit) and Non- | |
| engaging (Multi-unit) | ||
| Prosthesis Attachment | Screw-retained | Screw-retained |
| Collar height | 0.3, 0.4mm | 0.6mm |
| Collar diameter | 5, 5.7, 6mm | 7.2mm |
| Abutment Angle | 0° | 0° |
| Abutment Material | Unalloyed titanium (ASTM F67) | Unalloyed titanium (ASTM F67) |
| Abutment Screw Material | Titanium Alloy (ASTM F136) or | |
| Gold Alloy | Titanium Alloy (ASTM F136) or | |
| Gold Alloy | ||
| Compact Conical Abutment | ||
| Connection configurations | Non-engaging (Multi-unit) | N/A |
| Prosthesis Attachment | Screw-retained | N/A |
| Collar height | 1, 3, 5mm | N/A |
| Collar diameter | 6mm | N/A |
| Abutment Angle | 0° | 0° |
| Abutment Material | Titanium Alloy (ASTM F136) with | |
| TiN coating | N/A | |
| Abutment Screw Material | Titanium Alloy (ASTM F136) or | |
| Gold Alloy | N/A |
6
7
The Indications for Use Statement for the subject device is the same as that of the primary predicate device K071161, except for the names of the devices.
The primary predicate device K071161 is for substantial equivalence of the subject device implant design. The subject device implants have the identical design as the implants in K071161 with the exception of the diameter 6mm and 7mm implants, the length 6mm implant, the configuration of the implant where the implant surface is not roughened in the coronal 3mm of the implant body and the addition of a tri-lobe and internal hex connection system. The reference device K163634 is for substantial equivalence of the subject device diameter 6mm implant, the subject device length 6mm implant and the subject device with the unroughened coronal 3mm implant body. The reference device K070905 is for substantial equivalence of the subject device tri-lobe connection. The reference device K180465 is for substantial equivalence of the subject device internal hex connection.
The primary predicate device K071161 is for substantial evidence of the subject device Cover Screw. Healing Abutment, Titanium Cylinder, Titanium Abutment, Passive Abutment and Compact Conical Abutment designs.
The reference device K163634 is for substantial equivalence of the subject device Cosmetic Abutment and Gold Cylinder Abutment.
The reference device K163634 is for substantial equivalence of the subject device Coverscrew platform diameter, maximum diameter and material with anodizing; Healing Abutment collar height, collar diameter and material with anodizing: Titanium Cylinder Abutment collar diameter and material with anodizing; Cosmetic Abutment Cylinder connection configuration, prosthesis attachment, collar height, collar diameter and material; Gold Cylinder Abutment connection configuration, prosthesis attachment, collar height, collar diameter and material; Passive Abutment collar height and collar
8
diameter; Compact Conical Abutment connection configuration, prosthesis attachment, collar height and collar diameter.
The reference device K180465 is for substantial equivalence of the subject device Cosmetic Abutment material with anodizing: Passive Abutment collar height: Compact Conical Abutment material with TiN coating.
The subject device and the predicate and reference devices all incorporate the same materials and encompass similar ranges of dimensions. The surface treatment applied to the endosseous threads of the subject device implants is identical to that cleared in K071161. All subject device components are for single-patient, single-use, and all are provided sterile except for the subject device Gold Cylinder abutments and Passive Abutments, which are to be moist heat sterilized. Similarly, the components cleared in K071161 and K163634 are for single patient, single-use and are provided sterile except for the Gold Cylinder abutments and Passive Abutments, which are to be moist heat sterilized. Substantial equivalence of the subject device components in terms of biocompatibility is supported by the fact that materials are identical in formulation, processing, component interactions, and storage conditions to the primary predicate device K071161 and reference devices K163634 and K180465.
In support of substantial equivalence in terms of mechanical performance, engineering analysis and dimensional analysis was performed and demonstrated fatigue performance of the subject device to be substantially equivalent to that of the predicate device K071161and reference devices K163634 and K180465. Pullout tests and surface area analysis demonstrated that the subject device is substantially equivalent to the reference device K163634.
CONCLUSION
The subject device and the predicate and reference devices have intended use, have similar technological characteristics, and are made of similar materials. The subject device and the predicate and reference devices encompass the same range of physical dimensions, including diameter and length of the implants, and the diameter and angulation of the abutments. The subject device and the predicate and reference devices are packaged in similar materials and sterilized using similar methods.
The data included in this submission demonstrate substantial equivalence to the predicate and reference devices listed above.